However, Wang et al. (16) reported that patients with high YAP expression levels had poor prognosis in CRC, especially when TAZ was co-expressed, but at multivariate analysis TAZ alone showed no statistical correlation to prognosis. The gene discussed is YAP1; the disease is colorectal carcinoma.